Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Arteriotomy Closure Devices are used to achieve hemostasis of an arterial puncture site after an angiography interventions, percutaneous coronary interventions or a peripheral interventions. GlobalData uses proprietary data and analytics to provide a comprehensive report on the arteriotomy closure devices devices market, including market shares of different players within South Korea. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the arteriotomy closure devices market in South Korea was Terumo followed by Abbott Laboratories, Teleflex, Merit Medical Systems, Cordis, Haemonetics, Medtronic and LeMaitre Vascular.
Arteriotomy Closure Devices are used to decrease vascular complications and reduce the time to hemostasis and ambulation compared to the traditional methods such as manual or mechanical compression. Passive Closure Devices and Active Closure Devices are tracked under Arteriotomy Closure Devices. Arteriotomy Closure Devices tracked here are used only in coronary interventions and peripheral vascular interventions. Active Closure Devices are used for the percutaneous closure of artery access sites in patients who have undergone diagnostic endovascular catheterization interventions. Passive Closure Devices provide controlled compression of the percutaneous access arteries without completely occluding vessel flow.
The value of the arteriotomy closure devices devices market within South Korea was expected to be over $7m in 2023.
For the latest complete market share analysis of arteriotomy closure devices device market in South Korea, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
